An association between ALDH1A1 and EGFR TKI resistance in lung CSCs has been investigated, wherein ALDH1A1+ lung cancer cells were found more resistant to gefitinib than the corresponding ALDH1A1− fraction [53]. This evidence concerns the gene EGFR and lung carcinoma.